ArticleCancers2021

Co-Stimulatory versus Cell Death Aspects of Agonistic CD40 Monoclonal Antibody Selicrelumab in Chronic Lymphocytic Leukemia.

Raquel Delgado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.